Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Dominik Bieg

2PUBLICATIONS

3CO-AUTHORS

Molecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (2)

Sort by Publication Date:

|Dec 27, 2018

MiR-424-3p suppresses galectin-3 expression and sensitizes ovarian cancer cells to cisplatin.

Dominik Bieg, Daniel Sypniewski, Ewa Nowak

|Sep 30, 2018

Morin decreases galectin-3 expression and sensitizes ovarian cancer cells to cisplatin.

Dominik Bieg, Daniel Sypniewski, Ewa Nowak

Pageof 1

Frequent Collaborators

2 joint publications

Daniel Sypniewski

2 joint publications

Ewa Nowak

2 joint publications

Ilona Bednarek

Frequent Collaborators

2 joint publications

Daniel Sypniewski

2 joint publications

Ewa Nowak

2 joint publications

Ilona Bednarek

Top Related Videos

Knockdown of <em>FAM83A</em> to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity

Knockdown of <em>FAM83A</em> to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity

Published on : Feb 09, 2024

See more related videos

Top Related Videos

Knockdown of <em>FAM83A</em> to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity

Knockdown of <em>FAM83A</em> to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity

Published on : Feb 09, 2024

See more related videos